Body Supplements – Phenibut HCL Vega Caps 200mg (90 pcs)

€ 43,95

Phenibut HCL Vega Caps are a capsule-format research material associated with phenibut hydrochloride, a synthetic phenyl-substituted derivative of gamma-aminobutyric acid (GABA). Raw Lab Chems presents this material exclusively for controlled chemical identification, analytical characterization, salt-form comparison, and reference-oriented laboratory investigation. Product labeling does not independently establish batch-specific purity, content uniformity, or analytical verification.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-12953 Category:
Description

Phenibut HCL Vega Caps 200mg (90 pcs)

Product Overview

Phenibut HCL Vega Caps are described in the supplied information as a capsule-format laboratory research material containing phenibut hydrochloride, a synthetic compound structurally related to gamma-aminobutyric acid (GABA).

The product is identified as a hydrochloride salt preparation and is presented by Raw Lab Chems exclusively for controlled analytical and reference-oriented laboratory research.

The supplied catalog description identifies a nominal capsule presentation. However, label information alone does not independently establish the chemical content, purity, formulation uniformity, or analytical suitability of a particular batch.

The scientific emphasis is on chemical identity, salt-form characterization, structural classification, analytical method development, and reproducible laboratory documentation.

The original source includes numerous consumer-oriented and therapeutic statements. Those statements are not carried into this research-focused description because they do not establish verified specifications for the supplied laboratory material.

Chemical Identity & Classification

Phenibut is a synthetic phenyl-substituted derivative of gamma-aminobutyric acid.

The source identifies the hydrochloride form as phenibut HCL, distinguishing it from the corresponding free-acid preparation.

The following chemical identifiers are stated in the supplied material:

  • Chemical name: 4-Amino-3-phenylbutanoic acid hydrochloride
  • Molecular formula: C10H14ClNO2
  • Molecular weight: 215.68 g/mol
  • Chemical family: Phenyl-substituted GABA derivative
  • Identified form: Hydrochloride salt

These identifiers describe the chemical substance named in the source. They do not independently verify the identity, composition, or purity of the actual capsule contents.

The presence of a phenyl substituent distinguishes phenibut structurally from unsubstituted GABA.

This distinction is relevant to chemical classification and comparative analytical investigation.

Researchers seeking additional chemical-reference information may consult PubChem, ensuring that any selected database record corresponds to the hydrochloride form rather than another preparation.

Chemical & Physical Characteristics

The supplied product is presented in capsule form and identifies phenibut hydrochloride as its named research compound.

The hydrochloride designation is relevant to chemical characterization because salt forms may differ from their corresponding free-acid preparations in physical properties and analytical behavior.

The original source describes differences in solubility between phenibut forms. However, no quantitative solubility measurements or supporting experimental records were provided.

Consequently, no numerical solubility specification is assigned to this product.

The source also does not establish the capsule-shell composition, excipients, fill appearance, particle size, melting point, crystalline form, hygroscopicity, or validated stability characteristics.

These properties should be determined from relevant batch documentation or independently generated analytical observations where required.

Because the product is presented as a formulated capsule material, laboratory analysis should distinguish characteristics of the named compound from those of any additional formulation components.

Purity & Analytical Verification

The supplied description does not provide a numerical purity percentage or a batch-specific Certificate of Analysis.

No chromatogram, mass spectrum, NMR spectrum, independent testing report, or other analytical record accompanied the source.

Accordingly, the chemical purity and identity of the actual supplied preparation remain unverified from the information available.

Analytical characterization may involve chromatographic, spectrometric, or spectroscopic methods selected and validated for the research objective.

These techniques may support investigations of chemical identity, impurity profiles, salt-form characteristics, and analytical method performance.

However, describing an analytical technique does not establish that it has been performed on the material offered under this product name.

Researchers should evaluate analytical findings in relation to the exact sample, batch, instrumentation, method limitations, and available reference materials.

A chemical formula or molecular-weight value is not a substitute for batch-specific analytical verification.

Quality Control & Batch Integrity

Reproducible laboratory investigation depends on clear sample identification, traceable material records, and appropriately documented analytical observations.

The supplied source does not establish a verified quality-management certification, a specific batch-testing protocol, or an independently confirmed content-uniformity specification.

Where available, relevant records may include supplier identification, batch number, chemical identity, receipt date, storage history, and analytical findings.

For capsule-format preparations, nominal label information should be distinguished from experimentally established composition.

Researchers should also document the analytical basis for identifying the hydrochloride form when salt-form differentiation is relevant to the investigation.

Without supporting batch records, no specific purity level, testing frequency, or manufacturing standard should be assumed.

The material’s stated chemical identity provides a starting point for research documentation rather than proof of laboratory-grade certification.

Safety, Handling & Laboratory Precautions

Phenibut hydrochloride is a pharmacologically active substance and should be managed using appropriate laboratory risk controls.

Research personnel should consult applicable chemical-safety information and institutional procedures before handling the material.

A laboratory risk assessment should address protective equipment, containment, contamination prevention, ventilation, access restrictions, accidental exposure, and disposal.

The supplied source discusses pharmacological activity involving GABA-related systems. Such information is relevant to hazard assessment but does not establish that the capsule preparation is safe for personal use.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Particular attention should be given to preventing accidental ingestion or unintended exposure.

Capsule packaging must not be interpreted as evidence of dietary-supplement approval, pharmaceutical authorization, or suitability for self-experimentation.

Packaging, Labeling & Storage

The supplied product is identified as a capsule-format preparation.

No independently verified capsule-shell composition, container specification, moisture-barrier performance, or packaging-validation record was supplied.

Laboratory packaging should preserve material identification and provide appropriate protection against contamination and unintended environmental exposure.

Inventory labels should identify the named compound, hydrochloride form, supplier, and available batch information.

The original source does not provide a validated storage temperature, shelf-life specification, or degradation study.

Consequently, no precise temperature range or expiration period is asserted.

Storage conditions should be determined using available supplier documentation, applicable safety information, and any relevant stability data.

Laboratory personnel should document packaging condition and material observations when those details affect sample traceability or analytical interpretation.

Intended Research Use & Market Positioning

The supplied chemical information places phenibut hydrochloride within research involving synthetic GABA derivatives, salt-form identification, structural characterization, and analytical method development.

Its hydrochloride designation provides a basis for comparing chemical forms without assuming equivalent physical properties or formulation characteristics.

For comparative catalog research, Raw Lab Chems also lists Phenibut FAA Vega Caps.

The free-acid and hydrochloride forms should be distinguished during chemical identification and analytical documentation.

Raw Lab Chems also lists Sulbutiamine Vega Caps, a separate synthetic research material associated with thiamine chemistry.

Sulbutiamine and phenibut hydrochloride are chemically distinct and should not be treated as interchangeable reference materials.

The supplied Phenibut HCL Vega Caps catalog reference identifies the product presentation discussed here.

These references provide catalog and comparative chemical context rather than evidence of equivalent composition, purity, or analytical performance.

Ordering, Availability & Fulfillment

The supplied information does not establish current inventory availability, verified shipping destinations, dispatch schedules, or independently documented transportation conditions.

Accordingly, no specific fulfillment or delivery guarantees are made.

Institutional research procurement should consider chemical identification, appropriate documentation, packaging integrity, permitted transportation arrangements, and relevant legal requirements.

Phenibut may be subject to restrictions that differ by jurisdiction.

Researchers and institutions should independently determine whether acquisition, possession, transfer, importation, exportation, and investigation of phenibut hydrochloride are lawful in their respective locations.

A research-use designation does not independently establish regulatory permission or exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Phenibut hydrochloride is presented exclusively as an experimental laboratory research material. Its regulatory treatment may vary according to jurisdiction, chemical form, formulation, and intended research activity.

Researchers and institutions remain responsible for applicable requirements governing acquisition, possession, storage, transfer, importation, exportation, laboratory investigation, and disposal.

No medical approval, dietary-supplement approval, universal legal status, or authorization for personal use is implied by this description.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Body Supplements – Phenibut HCL Vega Caps 200mg (90 pcs)”
Shipping & Delivery